Dr. Christian Lehmann

By January 23, 2019

Clinical Researcher, Dalhousie


Dr. Christian Lehmann is Professor of Anesthesia, Pharmacology, Microbiology & Immunology and Physiology & Biophysics at Dalhousie University, Halifax, NS. He is Staff Anesthesiologist and Associate Medical Director of Research in the Department of Anesthesia, Pain Management and Perioperative Medicine, Nova Scotia Health Authority, Halifax. Dr. Lehmann has 25 years of experience in experimental and clinical inflammation research including studies on the mechanisms of pain. He is the author of morethan 150 original publications, 5 books, 13 book chapters, and almost 200 published abstracts. In 2009 he founded the RESIST (Research in the Endocannabinoid System in Inflammation, Sepsis and Trauma) group with Dr. Melanie Kelly (Pharmacology) and others at Dalhousie. He and his collaborators received funding for their research on the therapeutic modulation of the endogenous cannabinoid system and for related research projects from CIHR, NSERC, CFI, MITACS, NSHRF, and Innovacorp. Dr. Lehmann is co-founder of Panag Pharma Inc. – a Halifax-based company working on novel cannabinoid formulations for the treatment of pain and inflammation.